4 The role of eryptosis in patients 4.1 The role of eryptosis in non-dialysis-dependent patients Eryptosis, the programmed death of erythrocytes characterized by PS exposure on the cell membrane, has emerged as a critical contributor to renal anemia in non-dialysis-dependent chronic kidney disease (NDD-CKD), with estimated glomerular filtration rate (eGFR) identified as its key determinant (Bissinger et al., 2024)
Suppression of Glucagon Secretion: Decreased glucagon reduces hepatic gluconeogenesis and glycogenolysis
61 in strawberry and Chakraborty et al
Global Analysis of Plasma Lipids Identifies Liver-Derived Acylcarnitines as a Fuel Source for Brown Fat Thermogenesis
Broad therapeutic benefits: Beyond type 2 diabetes and obesity, it provides benefits in cardiovascular and neurodegenerative diseases, as well as MASH/NASH and related metabolic disorders
In a pig model, rivaroxaban reduced the weight of experimentally induced stent thrombus by 66% versus that in controls, and the effect size was dose-dependent, which suggests some degree of thrombin-mediated antithrombotic efficacy 92
